Zhende Medical Co., Ltd. (SHA:603301)
China
· Delayed Price · Currency is CNY 20.90
+0.07 (0.34%)
Jun 9, 2025, 2:45 PM CST
Zhende Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 4,275 | 4,247 | 4,105 | 6,131 | 4,907 | 10,311 | Upgrade
|
| Other Revenue | 16.67 | 16.67 | 21.6 | 6.47 | 184.42 | 87.78 | Upgrade
|
| Revenue | 4,292 | 4,264 | 4,127 | 6,138 | 5,092 | 10,399 | Upgrade
|
| Revenue Growth (YoY) | 13.22% | 3.32% | -32.76% | 20.54% | -51.04% | 456.75% | Upgrade
|
| Cost of Revenue | 2,874 | 2,850 | 2,850 | 4,063 | 3,353 | 5,568 | Upgrade
|
| Gross Profit | 1,418 | 1,414 | 1,277 | 2,075 | 1,738 | 4,830 | Upgrade
|
| Selling, General & Admin | 900.37 | 890.18 | 894.44 | 984.23 | 808.32 | 878.48 | Upgrade
|
| Research & Development | 139.48 | 135.49 | 138.95 | 227 | 153.14 | 259.71 | Upgrade
|
| Other Operating Expenses | 12.29 | 2.92 | 8.15 | 41.8 | 48.33 | 28.17 | Upgrade
|
| Operating Expenses | 1,058 | 1,039 | 1,043 | 1,262 | 1,011 | 1,184 | Upgrade
|
| Operating Income | 360.1 | 375.05 | 233.3 | 812.89 | 727.2 | 3,646 | Upgrade
|
| Interest Expense | -25.52 | -28.73 | -28.93 | -33.54 | -25.07 | -18.32 | Upgrade
|
| Interest & Investment Income | 27.8 | 35.92 | 46.76 | 10.61 | 52.4 | 26.63 | Upgrade
|
| Currency Exchange Gain (Loss) | 24.3 | 24.3 | 11.76 | 21.89 | -15.69 | -94.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -14.68 | -2.87 | -1.98 | -1.03 | -2.07 | -4.52 | Upgrade
|
| EBT Excluding Unusual Items | 372 | 403.68 | 260.9 | 810.81 | 736.77 | 3,555 | Upgrade
|
| Impairment of Goodwill | - | - | -2.29 | -3.91 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -7.6 | -12.25 | -21.06 | -71.06 | -2.7 | -2.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | 93.01 | 93.43 | -15.96 | -13.53 | -0.61 | 0.04 | Upgrade
|
| Asset Writedown | -4.27 | -9.09 | -52.02 | -4.97 | -3.31 | -48.4 | Upgrade
|
| Other Unusual Items | -1.32 | -0.31 | 49.34 | 84.38 | 89.81 | 28.8 | Upgrade
|
| Pretax Income | 451.82 | 475.46 | 218.89 | 801.72 | 819.95 | 3,533 | Upgrade
|
| Income Tax Expense | 77.43 | 78.25 | 5.49 | 99.96 | 99 | 561.19 | Upgrade
|
| Earnings From Continuing Operations | 374.39 | 397.21 | 213.4 | 701.76 | 720.95 | 2,972 | Upgrade
|
| Minority Interest in Earnings | -11.37 | -12.04 | -15 | -21.88 | -125.08 | -422.45 | Upgrade
|
| Net Income | 363.01 | 385.17 | 198.4 | 679.88 | 595.86 | 2,549 | Upgrade
|
| Net Income to Common | 363.01 | 385.17 | 198.4 | 679.88 | 595.86 | 2,549 | Upgrade
|
| Net Income Growth | 189.63% | 94.14% | -70.82% | 14.10% | -76.63% | 1524.99% | Upgrade
|
| Shares Outstanding (Basic) | 268 | 266 | 268 | 237 | 226 | 204 | Upgrade
|
| Shares Outstanding (Diluted) | 268 | 266 | 268 | 237 | 227 | 204 | Upgrade
|
| Shares Change (YoY) | 0.17% | -0.92% | 13.18% | 4.56% | 11.08% | 4.00% | Upgrade
|
| EPS (Basic) | 1.36 | 1.45 | 0.74 | 2.87 | 2.64 | 12.50 | Upgrade
|
| EPS (Diluted) | 1.36 | 1.45 | 0.74 | 2.87 | 2.63 | 12.50 | Upgrade
|
| EPS Growth | 189.14% | 95.95% | -74.22% | 9.13% | -78.96% | 1462.50% | Upgrade
|
| Free Cash Flow | -400.5 | -308.55 | -147.13 | 491.92 | 122.16 | 2,028 | Upgrade
|
| Free Cash Flow Per Share | -1.50 | -1.16 | -0.55 | 2.08 | 0.54 | 9.94 | Upgrade
|
| Dividend Per Share | 0.650 | 0.650 | 1.250 | - | 0.600 | 2.300 | Upgrade
|
| Dividend Growth | -48.00% | -48.00% | - | - | -73.91% | 648.94% | Upgrade
|
| Gross Margin | 33.04% | 33.16% | 30.93% | 33.80% | 34.14% | 46.45% | Upgrade
|
| Operating Margin | 8.39% | 8.80% | 5.65% | 13.24% | 14.28% | 35.06% | Upgrade
|
| Profit Margin | 8.46% | 9.03% | 4.81% | 11.08% | 11.70% | 24.52% | Upgrade
|
| Free Cash Flow Margin | -9.33% | -7.24% | -3.56% | 8.02% | 2.40% | 19.50% | Upgrade
|
| EBITDA | 596.01 | 612.37 | 476.27 | 998.26 | 858.7 | 3,725 | Upgrade
|
| EBITDA Margin | 13.89% | 14.36% | 11.54% | 16.27% | 16.86% | 35.82% | Upgrade
|
| D&A For EBITDA | 235.91 | 237.32 | 242.97 | 185.38 | 131.51 | 78.57 | Upgrade
|
| EBIT | 360.1 | 375.05 | 233.3 | 812.89 | 727.2 | 3,646 | Upgrade
|
| EBIT Margin | 8.39% | 8.80% | 5.65% | 13.24% | 14.28% | 35.06% | Upgrade
|
| Effective Tax Rate | 17.14% | 16.46% | 2.51% | 12.47% | 12.07% | 15.88% | Upgrade
|
| Revenue as Reported | 4,292 | 4,264 | 4,127 | 6,138 | 5,092 | 10,399 | Upgrade
|
| Advertising Expenses | - | 42.83 | 38.17 | 39.94 | 20.1 | 49.07 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.